Journal of Surgical Oncology

OCT 18, 2026 · JOURNAL ARTICLE

Hepatic Adenomas in Men: Diagnostic Considerations and Management in the Modern Era

Journal of Surgical Oncology

Hepatic adenomas (HAs) are rare benign liver tumors traditionally associated with young women, yet contemporary epidemiologic trends reveal increasing recognition among men. Histor

OCT 12, 2026 · JOURNAL ARTICLE

Chemotherapy After Resection of Pancreatic Ductal Adenocarcinoma: Impact of Different Regimens in a Real‐World Population

Journal of Surgical Oncology

INTRODUCTION: The PRODIGE 24/CCTG PA.6- trial has shown an overall survival (OS) up to 55 months in patients treated with (modified) 5-fluorouracil, leucovorin, irinotecan and oxal

SEP 27, 2026 · JOURNAL ARTICLE

Missed Opportunities for Multimodality Therapy in Resectable Pancreatic Cancer: National Disparities and Consequences for Survival

Journal of Surgical Oncology

ABSTRACT Background Multimodal therapy (MMT) combining surgery and chemotherapy remains the optimal management strategy irrespective of sequence for resectable pancreatic ductal ad

AUG 16, 2026 · JOURNAL ARTICLE

Optimal Management of Clinical T2N0 Gastric Adenocarcinoma: Surgery or Chemotherapy First?

Journal of Surgical Oncology

Large, well-powered observational cohort study from a national database demonstrating superior survival with adjuvant versus perioperative chemotherapy in cT2N0 gastric cancer, with multivariable analysis and clear effect sizes, though observational design limits causal inference.

AUG 10, 2026 · JOURNAL ARTICLE

The Role of Serial Serum Carbohydrate Antigen 19‐9 Surveillance to Detect Recurrences after Curative Resection for Gallbladder Carcinoma

Journal of Surgical Oncology

A single-centre retrospective analysis of a prospectively maintained database showing that CA 19-9 surveillance detects recurrence in gallbladder cancer with modest sensitivity (45.6% for serial rise) and high specificity (95.3%), with a median lead time of 5.4 weeks before radiological detection.